The efficacy of killing lung cancer cells and apoptosis induction by the LHRH-NLC-TAX multifunctional complex system was compared with a traditional clinically used EGFR-TK inhibitor - gefitinib (Figure 5). This evidence concerns the gene TKT and lung carcinoma.